Japan approves drug to treat Alzheimer's disease
Japan's health ministry has officially approved the domestic production and sale of a new drug for Alzheimer's disease. Donanemab was developed by U.S. pharmaceutical firm Eli Lilly. The ministry gave the greenlight on October …